SINGAPORE - Shanghai Turbo Enterprises said on Wednesday (Oct 25) that it had received a requisition letter for an extraordinary general meeting to remove the entire board last Friday. The letter, which had no sender's address, is purportedly from Mr Liu ... ( read original story ...)
Shanghai growth will free up renminbi
"Shanghai is the most important financial centre in China but ... Australian firms identified benefits in more favourable pricing and the ability to accommodate their Chinese business partners. Chinese companies identified improved trade terms as one ... ( read original story ...)
Chart of the day: Shanghai firms on a roll
Chinese companies whose names start with “Shanghai” are riding the recent buying frenzy among stock traders. In October, Shanghai party secretary Han Zheng said the city was drawing up a plan for a free-trade port, a term that was mentioned in ... ( read original story ...)
Tesla eyes Shanghai factory as electric car company looks to expand manufacturing base
Elon Musk’s Tesla electric car company is reported to have struck a deal with Chinese authorities to build a factory in Shanghai, opening up the world’s largest automotive market to the fast-growing business. Tesla is reported to have agreed to set up ... ( read original story ...)
Tesla to build wholly-owned Shanghai plant: WSJ
Tesla has reached an agreement with Shanghai authorities that would make it the first foreign automaker to build its own plant in China, putting it in the driver's seat in the world's biggest electric-vehicle market, the Wall Street Journal reported. ( read original story ...)
Shanghai stocks get FTZ boost
Shanghai-related stocks advanced on Friday as the city's Party chief confirmed plans to reinvent its pilot free trade zone as a world-class free port. The port has entered the "planning stage" and needs to get the green light from the central authorities ... ( read original story ...)
Shanghai Pharma bids for U.S. Cardinal Health’s China business
HONG KONG (Reuters) - Shanghai Pharmaceuticals Holding Co has bid for Cardinal Health Inc’s China business as the U.S. company looks to sell ahead of China’s planned drug distribution reform. Shanghai Pharma submitted two non-binding bids to buy ... ( read original story ...)